We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATYR
2551
aTyr Pharma
ATYR
$54.2M
$38K ﹤0.01%
17,443
-23,522
-57% -$55.5K
NEWR
2552
DELISTED
New Relic, Inc.
NEWR
$38K ﹤0.01%
667
+485
+266% +$27.4K
AURA icon
2553
Aura Biosciences
AURA
$791M
$37K ﹤0.01%
3,535
+2,273
+180% +$28.9K
CAE icon
2554
CAE Inc. Common Shares
CAE
$8.47B
$37K ﹤0.01%
1,912
-8,525
-82% -$164K
CNDT icon
2555
Conduent
CNDT
$252M
$37K ﹤0.01%
9,159
-15,104
-62% -$57.9K
COOK icon
2556
Traeger
COOK
$166M
$37K ﹤0.01%
262
+200
+323% +$33.4K
CRON
2557
Cronos Group
CRON
$1.16B
$37K ﹤0.01%
14,565
+8,076
+124% +$23.7K
CVAC
2558
DELISTED
CureVac
CVAC
$37K ﹤0.01%
6,208
+4,589
+283% +$33.9K
EWZ icon
2559
iShares MSCI Brazil ETF
EWZ
$8.55B
$37K ﹤0.01%
1,322
+1,019
+336% +$31.1K
FN icon
2560
Fabrinet
FN
$20.3B
$37K ﹤0.01%
289
-3,131
-92% -$374K
FOLD
2561
DELISTED
Amicus Therapeutics
FOLD
$37K ﹤0.01%
2,980
-85,229
-97% -$959K
FOSL icon
2562
Fossil Group
FOSL
$330M
$37K ﹤0.01%
8,572
+1,465
+21% +$6.12K
HBM icon
2563
Hudbay
HBM
$11.8B
$37K ﹤0.01%
7,195
-2,416
-25% -$11.6K
HEI.A icon
2564
HEICO Corp Class A
HEI.A
$38.1B
$37K ﹤0.01%
304
-7,749
-96% -$946K
IMA
2565
ImageneBio Inc
IMA
$66.6M
$37K ﹤0.01%
1,160
+840
+263% +$26.8K
MNTK icon
2566
Montauk Renewables
MNTK
$268M
$37K ﹤0.01%
3,374
-4,092
-55% -$54.7K
SINT icon
2567
SiNtx Technologies
SINT
$10.9M
$37K ﹤0.01%
19
+18
+1,800% +$43.3K
SLF icon
2568
Sun Life Financial
SLF
$44.8B
$37K ﹤0.01%
787
-11,210
-93% -$496K
SPNT icon
2569
SiriusPoint
SPNT
$2.7B
$37K ﹤0.01%
6,306
-546
-8% -$3.21K
TAC icon
2570
TransAlta
TAC
$3.99B
$37K ﹤0.01%
4,121
-2,122
-34% -$19K
VCTR icon
2571
Victory Capital Holdings
VCTR
$7.27B
$37K ﹤0.01%
1,365
+566
+71% +$15.9K
XLC icon
2572
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
$37K ﹤0.01%
761
-329,321
-100% -$16.1M
ENZ
2573
DELISTED
Enzo Biochem, Inc.
ENZ
$37K ﹤0.01%
26,056
+224
+0.9% +$437
TCN
2574
DELISTED
Tricon Residential Inc.
TCN
$37K ﹤0.01%
4,847
-3,301
-41% -$27.5K
MACK
2575
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$37K ﹤0.01%
3,242
+3,057
+1,652% +$25.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.